The MAPK pathway agonist anisomycin was further administrated in ischemic stroke rats, in order to investigate the role of ATF3 in ischemic stroke and mitochondrial homeostasis through the MAPK pathway. This evidence concerns the gene ATF3 and ischemic stroke.